Literature DB >> 28408123

RNA-Binding Proteins in Female Reproductive Pathologies.

Kasra Khalaj1, Jessica E Miller1, Christian R Fenn1, SooHyun Ahn1, Rayana L Luna2, Lindsey Symons1, Stephany P Monsanto1, Madhuri Koti1, Chandrakant Tayade3.   

Abstract

RNA-binding proteins are key regulatory molecules involved primarily in post-transcriptional gene regulation of RNAs. Post-transcriptional gene regulation is critical for adequate cellular growth and survival. Recent reports have shown key interactions between these RNA-binding proteins and other regulatory elements, such as miRNAs and long noncoding RNAs, either enhancing or diminishing their response to RNA stabilization. Many RNA-binding proteins have been reported to play a functional role in mediation of cytokines involved in inflammation and immune dysfunction, and some have been classified as global post-transcriptional regulators of inflammation. The ubiquitous expression of RNA-binding proteins in a wide variety of cell types and their unique mechanisms of degradative action provide evidence that they are involved in reproductive tract pathologies. Aberrant inflammation and immune dysfunction are major contributors to the pathogenesis and disease pathophysiology of many reproductive pathologies, including ovarian and endometrial cancers in the female reproductive tract. Herein, we discuss various RNA-binding proteins and their unique contributions to female reproductive pathologies with a focus on those mediated by aberrant inflammation and immune dysfunction.
Copyright © 2017 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28408123     DOI: 10.1016/j.ajpath.2017.01.017

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  6 in total

1.  Global profiling of RNA-binding protein target sites by LACE-seq.

Authors:  Ruibao Su; Li-Hua Fan; Changchang Cao; Lei Wang; Zongchang Du; Zhaokui Cai; Ying-Chun Ouyang; Yue Wang; Qian Zhou; Ligang Wu; Nan Zhang; Xiaoxiao Zhu; Wen-Long Lei; Hailian Zhao; Yong Tian; Shunmin He; Catherine C L Wong; Qing-Yuan Sun; Yuanchao Xue
Journal:  Nat Cell Biol       Date:  2021-06-09       Impact factor: 28.824

2.  Distinct Roles of NANOS1 and NANOS3 in the Cell Cycle and NANOS3-PUM1-FOXM1 Axis to Control G2/M Phase in a Human Primordial Germ Cell Model.

Authors:  Erkut Ilaslan; Krystyna Kwiatkowska; Maciej Jerzy Smialek; Marcin Piotr Sajek; Zaneta Lemanska; Matisa Alla; Damian Mikolaj Janecki; Jadwiga Jaruzelska; Kamila Kusz-Zamelczyk
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

3.  Tristetraprolin specifically regulates the expression and alternative splicing of immune response genes in HeLa cells.

Authors:  Yafang Tu; Xiongfei Wu; Fengyun Yu; Jianzhong Dang; Juan Wang; Yaxun Wei; Zhitao Cai; Zhipeng Zhou; Wenliang Liao; Lian Li; Yi Zhang
Journal:  BMC Immunol       Date:  2019-05-02       Impact factor: 3.615

4.  The Expression of Cold-Inducible RNA-Binding Protein mRNA in Sow Genital Tract Is Modulated by Natural Mating, But Not by Seminal Plasma.

Authors:  Jaume Gardela; Mateo Ruiz-Conca; Cristina A Martinez; Dominic Wright; Manel López-Béjar; Heriberto Rodriguez-Martinez; Manuel Alvarez-Rodriguez
Journal:  Int J Mol Sci       Date:  2020-07-27       Impact factor: 5.923

5.  Prognostic Values From Integrated Analysis of the Nomogram Based on RNA-Binding Proteins and Clinical Factors in Endometrial Cancer.

Authors:  Shuang Yuan; Xiao Sun; Lihua Wang
Journal:  Clin Med Insights Oncol       Date:  2022-09-28

6.  RNA Binding Motif 5 (RBM5) in the CNS-Moving Beyond Cancer to Harness RNA Splicing to Mitigate the Consequences of Brain Injury.

Authors:  Travis C Jackson; Patrick M Kochanek
Journal:  Front Mol Neurosci       Date:  2020-07-15       Impact factor: 5.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.